Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
Genetic testing and molecular biomarkers 2017 Sep .
Ju Shang, Gao Yu, Cao Xin, Zhang Xiao-Fu, Yan Cheng-Cheng, Liu Feng-To
Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy.
Journal of thrombosis and haemostasis : JTH 2013 Aug 11 (8): 1617-9.
Blondon M, Wiggins K L, Harrington L B, Psaty B M, Smith N